{'fraction_non_alphanumeric': 0.018272425249169437, 'fraction_numerical': 0.0, 'mean_word_length': 5.347368421052631, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Improving treatment for tumor lysis syndrome: strategies for every oncology nurse.

Tumor lysis syndrome (TLS) is an oncologic emergency that occurs when a large number of rapidly dividing cells is lysed. Patients with cancer who have massive tumor burden with cells that are rapidly dividing are at particular risk for this potentially life-threatening complication. This program discussed the risk factors for developing TLS, the laboratory data used to diagnose the syndrome, the signs and symptoms associated with each of the metabolic abnormalities related to the syndrome, and patient management.